Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Gri Bio Inc (GRI)

Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
GRI Bio to Participate in the Virtual Investor Closing Bell Series GlobeNewswire - Fri Dec 6, 7:35AM CST

GRI : 0.7400 (-3.90%)
GRI Bio Presents Positive Preclinical Data on GRI-0621 for Treating Pulmonary Fibrosis at AFDD Summit Quiver Quantitative, Inc. - Thu Nov 21, 5:52PM CST

GRI Bio presented preclinical data on GRI-0621, showing its potential to treat idiopathic pulmonary fibrosis by inhibiting iNKT cell activity.Quiver AI SummaryGRI Bio, Inc. presented positive preclinical...

GRI : 0.7400 (-3.90%)
GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF) GlobeNewswire - Thu Nov 21, 7:45AM CST

GRI : 0.7400 (-3.90%)
GRI Bio, Inc. Reports $13.9 Million in Gross Proceeds and Provides Update on GRI-0621 Phase 2a Study for IPF Treatment Quiver Quantitative, Inc. - Fri Nov 15, 1:36AM CST

GRI Bio raised $13.9 million, extending its cash runway for GRI-0621's Phase 2a study in idiopathic pulmonary fibrosis.Quiver AI SummaryGRI Bio, Inc. announced it has raised $13.9 million in gross proceeds...

GRI : 0.7400 (-3.90%)
GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis GlobeNewswire - Thu Nov 14, 3:20PM CST

GRI : 0.7400 (-3.90%)
GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024 GlobeNewswire - Thu Oct 24, 7:30AM CDT

GRI : 0.7400 (-3.90%)
GRI Bio Announces Exercise of Warrants GlobeNewswire - Mon Oct 21, 4:35PM CDT

GRI : 0.7400 (-3.90%)
GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621’s Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF) GlobeNewswire - Wed Oct 16, 7:45AM CDT

GRI : 0.7400 (-3.90%)
GRI Bio to Present at the 22nd International Colloquium on Lung and Airway Fibrosis GlobeNewswire - Mon Oct 7, 7:30AM CDT

GRI : 0.7400 (-3.90%)
JTC Team Announces Presenting Company Line Up for the Virtual Investor “Ask the CEO” Conference Being Held October 24-25, 2023 ACCESSWIRE - Wed Oct 18, 2023

- Live video webcast interactive Q&A with participating companies -

EVFM : 0.0094 (-4.08%)
GRI : 0.7400 (-3.90%)
MBRX : 1.6700 (-7.73%)
XBIO : 4.29 (+0.23%)
AREC : 1.0700 (+0.94%)
CNSP : 0.1080 (-1.82%)
NVNO : 2.49 (-1.58%)
PALI : 1.7500 (-2.78%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot